Search

Your search keyword '"Ceriello, Antonio"' showing total 1,970 results

Search Constraints

Start Over You searched for: Author "Ceriello, Antonio" Remove constraint Author: "Ceriello, Antonio"
1,970 results on '"Ceriello, Antonio"'

Search Results

2. CVOT Summit Report 2023: new cardiovascular, kidney, and metabolic outcomes

3. GLP-1 receptor agonists-SGLT-2 inhibitors combination therapy and cardiovascular events after acute myocardial infarction: an observational study in patients with type 2 diabetes

5. New-Onset Diabetes Mellitus in COVID-19: A Scoping Review

6. Correction to: New-Onset Diabetes Mellitus in COVID-19: A Scoping Review

8. Indirect effects of the COVID-19 pandemic on diagnosing, monitoring, and prescribing in people with diabetes and strategies for diabetes service recovery internationally

13. Data from network meta-analyses can inform clinical practice guidelines and decision-making in diabetes management: perspectives of the taskforce of the guideline workshop

14. SGLT-2 inhibitors and in-stent restenosis-related events after acute myocardial infarction: an observational study in patients with type 2 diabetes

15. CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes

16. A global research priority agenda to advance public health responses to fatty liver disease

18. Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial

22. The Dual Pandemics of COVID-19 and Obesity: Bidirectional Impact

24. Evidence of an anti-inflammatory effect of PCSK9 inhibitors within the human atherosclerotic plaque

25. Continuous glucose monitoring and metrics for clinical trials: an international consensus statement

26. Downstaging Strategies Prior to Liver Transplantation

27. Molecular and pro-inflammatory aspects of COVID-19: The impact on cardiometabolic health

28. Post-COVID syndrome, inflammation, and diabetes

30. Postprandial Plasma Glucose With a Fasting Time of 4–7.9 h Is Positively Associated With Cancer Mortality in US Adults.

31. Micro-nanoplastics and cardiovascular diseases: evidence and perspectives.

32. Inflammatory Trajectory of Type 2 Diabetes: Novel Opportunities for Early and Late Treatment.

36. Report from the CVOT Summit 2021: new cardiovascular, renal, and glycemic outcomes

39. Testing and Visualization of Associations in Three-Way Contingency Tables: A Study on Gender Gap in Patients with Type I Diabetes and Cardiovascular Complications

40. Disparities in prevalence and treatment of diabetes, cardiovascular and chronic kidney diseases – Recommendations from the taskforce of the guideline workshop

46. Race/ethnicity and challenges for optimal insulin therapy

47. CVOT Summit Report 2023:new cardiovascular, kidney, and metabolic outcomes

48. Diabetic myocardial disorder. A clinical consensus statement of the Heart Failure Association of the ESC and the ESC Working Group on Myocardial & Pericardial Diseases.

49. Testing and Visualization of Associations in Three-Way Contingency Tables: A Study of the Gender Gap in Patients with Type 1 Diabetes and Cardiovascular Complications.

Catalog

Books, media, physical & digital resources